ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48 | -48.9% | 24,701 | 0.0% | 0.00% | – |
| Q4 2022 | $94 | -99.9% | 24,701 | -1.1% | 0.00% | -100.0% |
| Q3 2022 | $120,000 | -39.4% | 24,971 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $198,000 | -45.8% | 25,060 | +0.4% | 0.00% | -50.0% |
| Q1 2022 | $365,000 | -27.4% | 24,971 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $503,000 | -25.7% | 24,971 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $677,000 | +11.5% | 24,971 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $607,000 | -68.7% | 24,971 | -68.5% | 0.00% | -76.9% |
| Q1 2021 | $1,938,000 | -23.7% | 79,397 | 0.0% | 0.01% | -31.6% |
| Q4 2020 | $2,541,000 | – | 79,397 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 11,167,800 | $24,010,770 | 3.60% |
| Sio Capital Management, LLC | 4,020,705 | $8,644,516 | 2.20% |
| Redmile Group, LLC | 14,049,935 | $30,207,360 | 1.16% |
| Vantage Consulting Group Inc | 885,520 | $1,903,868 | 1.10% |
| Blue Owl Capital Holdings LP | 733,568 | $1,577,171 | 0.97% |
| AlphaCentric Advisors LLC | 778,000 | $1,672,700 | 0.93% |
| Affinity Asset Advisors, LLC | 600,000 | $1,290,000 | 0.45% |
| GCM Grosvenor Holdings, LLC | 410,888 | $883,409 | 0.38% |
| Indie Asset Partners, LLC | 93,839 | $201,754 | 0.22% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $3,541,115 | 0.21% |